- $605.38m
- $422.26m
Eliem Therapeutics surges following IPO pop
NASDAQ RESUMED AT 12:35 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:30 PM
Eliem Therapeutics jumps in Nasdaq debut
Brief: Eliem Therapeutics Shares Open 30% Above IPO Price In Nasdaq Debut
Brief: Eliem Therapeutics Says PRICED IPO Of 6.4 Mln Common Shares At $12.5/Shr
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:01 AM
Brief: Eliem Therapeutics Inc Says Now Sees IPO Of Up To 6 Mln Shares Of Common Stock Priced To Be $12.50 Per Share
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Eliem Therapeutics Inc Says IPO Price Is Expected To Be Between $17.00 And $19.00 Per Share